GSK Consumer Healthcare: Post open offer status

HSBC Securities and Capital Markets (India) Pvt Ltd ("Manager to the Open Offer") for and on behalf of GlaxoSmithKline Pte Ltd ("GSK Pte" or the "Acquirer") along with Horlicks Ltd ("Horlicks") and GlaxoSmithKline plc ("GSK plc") in their capacity as persons acting in concert (each entity individually referred to as "PAC" and together referred to as "PACs") has informed BSE a Post Offer Announcement to the Shareholders of the GlaxoSmithkline Consumer Healthcare Ltd ("Target Company"), pursuant to Regulation 18 (12) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations 2011 and subsequent amendments thereto (the “SEBI (SAST) Regulations, 2011”), in respect of the Voluntary Open Offer ("Open Offer") for the acquisition of 13,389,410 Shares representing 31.84% of the Voting Share Capital from the public shareholders of the Target Company.This Post Offer Announcement should be read in continuation of, and in conjunction with, the Public Announcement filed on 26 November 2012 ("PA"), the Detailed Public Statement published on December 04, 2012 ("DPS"), the Letter of Offer dated January 10, 2013 ("Letter of Offer") and the Offer Opening Announcement published on January 16, 2013.Source : BSE

Read all announcements in GlaxoSmith Con

Read More